The Market Reports

Synopsis
The global market for Anti-allergic Drugs was estimated to be worth US$ 44830 million in 2024 and is forecast to a readjusted size of US$ 70800 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Anti-allergic drugs are medications used to treat and prevent allergic reactions by targeting the immune system's response to allergens. These drugs help alleviate symptoms associated with allergies, such as sneezing, itching, runny nose, rashes, or swelling, and are commonly used for conditions like hay fever, allergic rhinitis, and skin allergies. Common types of anti-allergic drugs include antihistamines, corticosteroids, decongestants, and leukotriene inhibitors. These medications work by blocking histamines or other inflammatory substances that the body releases during an allergic reaction, reducing the severity of symptoms and providing relief to individuals suffering from allergies.
Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.
This report aims to provide a comprehensive presentation of the global market for Anti-allergic Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Anti-allergic Drugs by region & country, by Type, and by Sales Channel.
The Anti-allergic Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-allergic Drugs.
Market Segmentation
By Company
Sanofi
Johnson And Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
AstraZeneca
Roche
Novartis
Segment by Type
Oral Drugs
Non-Oral Drugs
Inhalation and Nasal Sprays
Segment by Sales Channel
Online
Offline
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-allergic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Anti-allergic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Anti-allergic Drugs in country level. It provides sigmate data by Type, and by Sales Channel for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index